Predicting onset of secondary-progressive multiple sclerosis using genetic and non-genetic factors.

Elina MisickaCorriene SeptFarren Basil Shaw Briggs

Published in: Journal of neurology (2020)

These results have the potential to advance prognostication for a person with MS using information available at or near onset, potentially improving care and quality of life for those who live with MS.

Keyphrases

multiple sclerosis
genome wide
white matter
mass spectrometry
healthcare
palliative care
ms ms
copy number
quality improvement
pain management
gene expression
risk assessment
affordable care act
chronic pain
health insurance